Your browser doesn't support javascript.
loading
Overview of tobacco use transitions for population health.
Hyland, Andrew; Kasza, Karin A; Borek, Nicolette; Kimmel, Heather L; Taylor, Kristie A; Compton, Wilson M; Day, Hannah; Donaldson, Elisabeth A; Sharma, Eva; Anic, Gabriella; Edwards, Kathryn C; Halenar, Michael J; Hull, Lynn C; Kissin, Wendy; Limpert, Jean; Seaman, Elizabeth L; Bansal-Travers, Maansi; Gardner, Lisa D; Hammad, Hoda T; Stanton, Cassandra A.
Afiliación
  • Hyland A; Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA andrew.hyland@roswellpark.org.
  • Kasza KA; Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Borek N; Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
  • Kimmel HL; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
  • Taylor KA; Behavioral Health and Health Policy Practice, Westat, Rockville, MD, USA.
  • Compton WM; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
  • Day H; Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
  • Donaldson EA; Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
  • Sharma E; Behavioral Health and Health Policy Practice, Westat, Rockville, MD, USA.
  • Anic G; Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
  • Edwards KC; Behavioral Health and Health Policy Practice, Westat, Rockville, MD, USA.
  • Halenar MJ; Behavioral Health and Health Policy Practice, Westat, Rockville, MD, USA.
  • Hull LC; Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
  • Kissin W; Behavioral Health and Health Policy Practice, Westat, Rockville, MD, USA.
  • Limpert J; Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
  • Seaman EL; Behavioral Health and Health Policy Practice, Westat, Rockville, MD, USA.
  • Bansal-Travers M; Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Gardner LD; Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
  • Hammad HT; Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
  • Stanton CA; Behavioral Health and Health Policy Practice, Westat, Rockville, MD, USA.
Tob Control ; 29(Suppl 3): s134-s138, 2020 05.
Article en En | MEDLINE | ID: mdl-32321846
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Productos de Tabaco / Uso de Tabaco / Prevención del Hábito de Fumar Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Tob Control Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Productos de Tabaco / Uso de Tabaco / Prevención del Hábito de Fumar Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Tob Control Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido